Liposomal Alendronate Inhibits Systemic Innate Immunity and Reduces In-Stent Neointimal Hyperplasia in Rabbits

Circulation

Volumn 108, Issue 22, 2003, Pages 2798-2804

  Danenberg, Haim D ^a,b,d   Golomb, Gershon ^c   Groothuis, Adam ^a   Gao, Jianchuan ^c   Epstein, Hila ^c   Swaminathan, Rajesh V ^a   Seifert, Philip ^a   Edelman, Elazer R ^a  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Angioplasty; Inflammation; Leukocytes; Restenosis; Stents

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; LIPOSOMAL ALENDRONATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON DILATATION; CELL COUNT; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; IMMUNITY; INTIMA; LIPID DIET; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; STENT; VASCULAR SURGERY;

ALENDRONATE; ANIMALS; CELL COUNT; CELL DIVISION; CELL MOVEMENT; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; ILIAC ARTERY; IMMUNITY, NATURAL; LEUKOCYTE COUNT; LIPOSOMES; MACROPHAGES; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; RABBITS; STENTS; TUNICA INTIMA;

EID: 0344664339     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000097002.69209.CD     Document Type: Article

References (33)

1. Hanke H, Hassenstein S, Ulmer A, et al. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur Heart J. 1994;15:691-698.
2. Okamoto E, Couse T, De Leon H, et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 2001;104:2228-2235.
3. Moreno P, Falk E, Palacios I, et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
4. Pietersma A, Kofflard M, de Wit LE, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995;91:1320-1325.
5. Danenberg H, Fishbein I, Gao J, et al. Macrophage depletion by clodronate-containing liposomes reduce neointimal hyperplasia in rats and rabbits. Circulation. 2002;106:599-605.
6. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94:1247-1254.
7. Feldman LJ, Mazighi M, Scheuble A, et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation. 2001;103:3117-3122.
8. Kollum M, Kaiser S, Kinscherf R, et al. Apoptosis after stent implantation compared with balloon angioplasty in rabbits: role of macrophages. Arterioscler Thromb Vasc Biol. 1997;17:2383-2388.
9. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation. 1995;91:2995-3001.
10. Rogers C, Welt FG, Karnovsky MJ, et al. Monocyte recruitment and neointimal hyperplasia in rabbits: coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol. 1996;16:1312-1318.
11. Rodan GA. Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol. 1998;38:375-388.
12. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev. 1998;19:80-100.
13. van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93.
14. Huitinga I, Damoiseaux J, van Rooijen N, et al. Liposome mediated affection of monocytes. Immunobiology. 1992;185:11-19.
15. Danenberg H, Welt F, Walker M, et al. Systemic inflammation induced by lipopolysaccharide increases neointimal formation following balloon and stent injury in rabbits. Circulation. 2002;105:2917-2922.
16. Feldman L, Aguirre L, Ziol M, et al. Interleukin-10 inhibits neointimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation. 2000;101:908-916.
17. Rogers C, Edelman ER, Simon DI. A mAb to the b2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA. 1998;95:10134-10139.
18. Mönkkönen J, Taskinen M, Auriolal SOK, et al. Growth inhibition of macrophage-like and other cell types by liposomes-encapsulated calcium-bound and free bisphosphonates in vitro. J Drug Target. 1994;2:299-308.
19. Fisher JE, Rodan GA, Reszka AA. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. Endocrinology. 2000;141:4793-4796.
20. Walter DH, Fichtlscherer S, Sellwig M, et al. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol. 2001;37:839-846.
21. Zairis MN, Ambrose JA, Manousakis SJ, et al. The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: the Global Evaluation of New Events and Restenosis After Stent Implantation Study. J Am Coll Cardiol. 2002;40:1375-1382.
22. Buffon A, Liuzzo G, Biasucci L, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol. 1999;34:1512-1521.
23. Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol. 2000;36:2168-2173.
24. Pepine C, Hirshfeld J, Macdonald R, et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group. Circulation. 1990;81:1753-1761.
25. Stone GW, Rutherford BD, McConahay DR, et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn. 1989;18:227-231.
26. Versaci F, Gaspardone A, Tomai F, et al. Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol. 2002;40:1935-1942.
27. van der Goes A, Hoekstra K, van den Berg TK, et al. Dexamethasone promotes phagocytosis and bacterial killing by human monocytes/macrophages in vitro. J Leukoc Biol. 2000;67:801-807.
28. Fingerote RJ, Abecassis M, Phillips MJ, et al. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity. J Virol. 1996;70:4275-4282.
29. Lu H, Smith C, Perrard J, et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1 deficient mice. J Clin Invest. 1997;99:1340-1350.
30. Wiktor-Jedrzejczak W, Ahmed A, Szczylik C, et al. Hematological characterization of congenital osteopetrosis in op/op mouse: possible mechanism for abnormal macrophage differentiation. J Exp Med. 1982;156:1516-1527.
31. Wijburg OL, van den Dobbelsteen GP, Vadolas J, et al. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens. Eur J Immunol. 1998;28:479-487.
32. Cipollone F, Marini M, Fazia M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2001;21:327-334.
33. Faxon DP. Systemic drug therapy for restenosis: "deja vu all over again." Circulation. 2002;106:2296-2298.